Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Microcephaly lymphoedema chorioretinal dysplasia

Congenital Malformations and Chromosomal Abnormalities

Microcephaly lymphoedema chorioretinal dysplasia, also known as lymphedema microcephaly chorioretinopathy syndrome, is a rare genetic condition defined by three features: a small head, swelling of the feet from lymphoedema, and changes in the retina called chorioretinal dysplasia. It was described as a distinct entity in 1992 by Feingold and Bartoshesky, who reported two unrelated children, and further cases were reported through 2001. Some children show only two of the features, either microcephaly with lymphoedema or microcephaly with chorioretinal dysplasia, with or without intellectual disability. Reported facial features include upslanting palpebral fissures, a broad nose with a rounded tip, a long philtrum with a thin upper lip, a pointed chin and prominent ears. The inheritance pattern varies between reports and has been described as autosomal dominant, autosomal recessive or X-linked.

Facts
Classification
ICD-10 Chapter
XVII: Congenital Malformations, Deformations and Chromosomal Abnormalities 1
Communicable or Non-communicable
Non-Communicable 2
Causative Agent
Causative Agent (category)
Genetic / Hereditary 2
First Described
1992 2
Sources
1. World Health Organization ICD-10: ICD-10 Version:2019 - Q80-Q89
World Health Organization ICD-10Category Q87.8
Quote, Category Q87.8
Q87.8 Other specified congenital malformation syndromes,
View the Source
2. Microcephaly lymphoedema chorioretinal dysplasia (Wikipedia)
  • Lead
    In 1992, Feingold and Bartoshesky described two unrelated children with microcephaly, lymphoedema and chorioretinal dysplasia (MIM 152950) as a distinct entity.
  • Lead [causative-agent-category]
    also known as lymphedema microcephaly chorioretinopathy syndrome is a rare genetic condition
  • Lead [disease-category]
    is a rare genetic condition associated with
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.